Drug intelligence / Profile preview

Lingmao Granules

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Lingmao Granules (灵猫颗粒) is a traditional Chinese medicine formulation administered as granules. It is used in clinical settings in China and has been studied in at least one registered clinical trial for oral administration, with a regimen of one package taken twice daily for 12 months. The specific herbal composition, mechanism of action, and primary indications are not detailed in the available sources. However, based on its use as a granule formulation and naming conventions typical to Chinese patent medicines, it likely contains multiple herbal ingredients designed to address specific health conditions according to traditional Chinese medical theory[1].

Brand names: Lingmao Granules
Other names: 灵猫颗粒1灵猫颗粒Lingmao Granules 1

Beyond the preview

Go deeper on Lingmao Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingmao Granules.

Explore the full profile